Zonisamide Capsule
Product Images NDC 71335-2797

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 71335-2797). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Zonisamide (Ae95556a 06c3 4e0e 9b9e 562ae444579c 01)

FDA Label Image

Structured Formula For Zonisamide (Ae95556a 06c3 4e0e 9b9e 562ae444579c 02)

Structured Formula For Zonisamide (Ae95556a 06c3 4e0e 9b9e 562ae444579c 02)
This text seems to include information about the reduction in partial seizures rate following treatment with Zonisamide capsules. It appears to show a percentage reduction in seizures among patients.*
FDA Label Image

Label (Lbl713352797)

Label (Lbl713352797)
This text provides information about Zonisamide capsules containing 100 mg of USP graded Zonisamide. It includes details on usual dosage and storage instructions. Additionally, it instructs pharmacists to dispense a medication guide to each patient and highlights that the package is child-resistant. The text also mentions the manufacturer, Bryant Ranch Prepack, Inc., and indicates that the capsules are repackaged by Zydus Lifesciences Ltd.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.